Maryam Lustberg: Global conversations on access to drugs and clinical trials in oncology / access to drugs, ASCO, cancer, clinical trials, CPOEM, Global

Inside the Biotech Frontier: Chris Burns on Amplia’s Vision and Cancer Drug Development / Amplia Therapeutics, cancer, Chris Burns, OncoDaily, Oncology,

Biotech firm BioCorteX uses what may be the world’s largest biological knowledge graph to understand how bacteria impact the effectiveness of cancer drugs.

Researchers have discovered a mechanism that renders cell therapies ineffective against multiple myeloma. They were able to stop it with a cancer drug.

Hugely promising cancer drug dostarlimab is one step closer to being widely available, after the Food and Drug Administration granted it Breakthrough Therapy Designation status that, if successful, wi...

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical trials for ovarian and bile duct cancer, according to research published in...

Yeast engineered to produce cancer drug precursors

UCSF scientists developed a way to deliver radiation just to cancerous cells, rather than attacking both cancerous and healthy tissue. The therapy combines a drug to mark the cancer cells for destruct...

Like many Americans, Scott Adams had insurance problems. But unlike most people he has powerful friends on social media, and when he asked President Trump for help, he got the cancer drug he needed.

A TOR-targeting cancer drug unexpectedly extends yeast lifespan through a newly discovered metabolic feedback loop. Researchers at Queen Mary University of London’s School of Biological and Behavioura...

A redesigned immune-activating cancer drug has produced striking early results in a small clinical trial, shrinking tumors and sometimes eliminating them entirely.

Deal with Absci is the latest between big pharma and tech companies to build new disease treatments

NEW YORK (AP) - Life expectancy in the United States will rise to 79 years in 2024, the highest in U.S. history. It's not just a dissipated result. COVID-19 pandemicBut death rates from the nation's leading killers, including heart disease, are also declining. cancerdrug overdose. Moreover, preliminary statistics suggest that improvements will continue in 2025. Related: Growth in average human lifespan may have already peaked "Overall, it's pretty good news," said Robert Anderson of the U.S. Centers for Disease Control and Prevention's National Center for Health Statistics, who released the 2024 data on Thursday.